What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in Molecular biology, Immunology, Cell biology, Ephrin and Erythropoietin-producing hepatocellular receptor.
His Molecular biology research incorporates themes from Antibody, Monoclonal antibody, B cell, Antigen and Receptor.
His Immunology research is multidisciplinary, relying on both Colony-stimulating factor and Haematopoiesis.
His studies examine the connections between Cell biology and genetics, as well as such issues in Cell adhesion, with regards to ICAM-1 and Cell adhesion molecule.
His studies deal with areas such as Cell signaling and Neuroscience as well as Ephrin.
His study ties his expertise on EPH receptor A2 together with the subject of Erythropoietin-producing hepatocellular receptor.
His most cited work include:
- The isolation and characterization of the human helper inducer T cell subset. (618 citations)
- Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells (431 citations)
- Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling (390 citations)
What are the main themes of his work throughout his whole career to date?
Andrew W. Boyd spends much of his time researching Molecular biology, Immunology, Cancer research, Cell biology and Erythropoietin-producing hepatocellular receptor.
Andrew W. Boyd has researched Molecular biology in several fields, including Haematopoiesis, Progenitor cell, Antibody, B cell and Antigen.
His Immunology research incorporates elements of Cytotoxic T cell and Interleukin 12.
His Cancer research study also includes
-
Leukemia which connect with Myeloid leukemia,
-
Bone marrow most often made with reference to Stem cell.
His study on Cell biology also encompasses disciplines like
-
Cell adhesion which connect with Cell adhesion molecule,
-
Cell culture which connect with Tumor suppressor gene.
His Erythropoietin-producing hepatocellular receptor research is multidisciplinary, incorporating elements of Inflammation, EPH receptor A2, Neuroscience and Ephrin.
He most often published in these fields:
- Molecular biology (36.97%)
- Immunology (31.69%)
- Cancer research (29.58%)
What were the highlights of his more recent work (between 2016-2020)?
- Cancer research (29.58%)
- Cell biology (28.87%)
- Receptor (14.79%)
In recent papers he was focusing on the following fields of study:
Andrew W. Boyd mostly deals with Cancer research, Cell biology, Receptor, Stem cell and Glioma.
His work in the fields of Cell biology, such as Progenitor cell, overlaps with other areas such as LYL1.
Antagonist, Erythropoietin-producing hepatocellular receptor and EPH receptor A2 are among the areas of Receptor where Andrew W. Boyd concentrates his study.
His Therapeutic targeting research includes elements of Immunology, Monoclonal antibody and Immunotherapy.
His Epitope research includes themes of Molecular biology and Immunotoxin.
His Neuroscience study combines topics from a wide range of disciplines, such as Amyotrophic lateral sclerosis and Signal transduction, Receptor tyrosine kinase.
Between 2016 and 2020, his most popular works were:
- Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways. (34 citations)
- A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma. (31 citations)
- A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma. (31 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in Immunology, Monoclonal antibody, Stem cell, Erythropoietin-producing hepatocellular receptor and Immunotherapy.
He has included themes like Plasma protein binding and Receptor, Antagonist, Ectodomain, Ephrin in his Immunology study.
As part of his studies on Monoclonal antibody, Andrew W. Boyd frequently links adjacent subjects like Cancer research.
His research investigates the link between Stem cell and topics such as Phenotype that cross with problems in Cell culture, Plasmid and CRISPR.
In his research, he undertakes multidisciplinary study on Erythropoietin-producing hepatocellular receptor and Immunoglobulin Fc Fragments.
His research integrates issues of Therapeutic targeting, Lymphoblastic Leukemia, Function, EPHA3 Gene and Therapeutic effect in his study of Immunotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
